Envestnet Portfolio Solutions Inc. Sells 1,515 Shares of Integer Holdings Corporation (NYSE:ITGR)

Envestnet Portfolio Solutions Inc. lowered its stake in shares of Integer Holdings Corporation (NYSE:ITGR) by 25.6% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,394 shares of the medical equipment provider’s stock after selling 1,515 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Integer were worth $519,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Arizona State Retirement System lifted its position in Integer by 0.9% during the 4th quarter. Arizona State Retirement System now owns 9,732 shares of the medical equipment provider’s stock valued at $1,290,000 after purchasing an additional 84 shares during the period. HighPoint Advisor Group LLC raised its holdings in Integer by 6.4% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,684 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 101 shares during the period. Norden Group LLC grew its stake in shares of Integer by 7.0% during the 4th quarter. Norden Group LLC now owns 1,668 shares of the medical equipment provider’s stock worth $221,000 after acquiring an additional 109 shares in the last quarter. Corient Private Wealth LLC grew its stake in shares of Integer by 6.4% during the 4th quarter. Corient Private Wealth LLC now owns 1,969 shares of the medical equipment provider’s stock worth $261,000 after acquiring an additional 118 shares in the last quarter. Finally, Principal Securities Inc. grew its stake in shares of Integer by 31.2% during the 4th quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider’s stock worth $85,000 after acquiring an additional 152 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Insider Transactions at Integer

In related news, Director Donald J. Spence sold 14,739 shares of the stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the sale, the director now directly owns 18,781 shares of the company’s stock, valued at approximately $2,260,856.78. This represents a 43.97% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Joseph W. Dziedzic sold 338,975 shares of the firm’s stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the sale, the chief executive officer now directly owns 47,000 shares in the company, valued at approximately $5,788,990. The trade was a 87.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 362,434 shares of company stock valued at $44,577,115 in the last three months. 2.16% of the stock is currently owned by company insiders.

Integer Trading Up 0.8%

NYSE:ITGR opened at $121.81 on Friday. The company has a fifty day moving average of $120.17 and a 200 day moving average of $126.26. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The company has a quick ratio of 2.14, a current ratio of 3.40 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $4.25 billion, a P/E ratio of 57.73, a P/E/G ratio of 1.04 and a beta of 0.98.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.14 EPS. On average, research analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on ITGR shares. Wall Street Zen raised Integer from a “sell” rating to a “hold” rating in a report on Monday, May 19th. Raymond James Financial boosted their target price on Integer from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, April 25th. Truist Financial set a $150.00 price objective on shares of Integer and gave the company a “buy” rating in a report on Friday, April 25th. Citigroup raised shares of Integer from a “hold” rating to a “strong-buy” rating and increased their target price for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. Finally, KeyCorp reduced their price objective on shares of Integer from $154.00 to $145.00 and set an “overweight” rating for the company in a research report on Monday, April 21st. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $145.00.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.